Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Diazoxide Choline Controlled-Release Tablet (DCCR) in Subjects Without Diabetes Mellitus Having Very High Fasting Triglyceride Levels, With Double-Blind DCCR-Fenofibrate Combination Extension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Diazoxide (Primary) ; Atorvastatin; Fenofibrate
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Sponsors Essentialis; Soleno Therapeutics
- 01 Mar 2012 Primary endpoint 'Triglyceride-levels' has been met.
- 01 Jan 2012 Status changed from active, no longer recruiting to completed.
- 16 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.